BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1279971)

  • 1. Deletion of the KIT and PDGFRA genes in a patient with piebaldism.
    Spritz RA; Droetto S; Fukushima Y
    Am J Med Genet; 1992 Nov; 44(4):492-5. PubMed ID: 1279971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
    Spritz RA; Strunk KM; Lee ST; Lu-Kuo JM; Ward DC; Le Paslier D; Altherr MR; Dorman TE; Moir DT
    Genomics; 1994 Jul; 22(2):431-6. PubMed ID: 7528718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene.
    Giebel LB; Strunk KM; Holmes SA; Spritz RA
    Oncogene; 1992 Nov; 7(11):2207-17. PubMed ID: 1279499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
    Fleischman RA
    J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the c-kit protooncogene in the human developmental defect piebald trait.
    Fleischman RA; Saltman DL; Stastny V; Zneimer S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10885-9. PubMed ID: 1720553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.
    Sihto H; Franssila K; Tanner M; Vasama-Nolvi C; Sarlomo-Rikala M; Nupponen NN; Joensuu H; Isola J
    Scand J Gastroenterol; 2006 Jul; 41(7):805-11. PubMed ID: 16785193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.
    Spritz RA; Holmes SA; Ramesar R; Greenberg J; Curtis D; Beighton P
    Am J Hum Genet; 1992 Nov; 51(5):1058-65. PubMed ID: 1384325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A novel KIT gene mutation from a family with piebaldism in the southern part of China].
    Deng WP; Huang YS; Lu C; Lan W; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):668-70. PubMed ID: 16331568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III.
    André C; Martin E; Cornu F; Hu WX; Wang XP; Galibert F
    Oncogene; 1992 Apr; 7(4):685-91. PubMed ID: 1373482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel KIT gene mutation results in piebaldism].
    Deng WP; Lu C; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):545-7. PubMed ID: 16220461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
    Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H
    J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Holmes SA; Itin P; Küster W
    J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Giebel LB; Holmes SA
    Am J Hum Genet; 1992 Feb; 50(2):261-9. PubMed ID: 1370874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism.
    Ezoe K; Holmes SA; Ho L; Bennett CP; Bolognia JL; Brueton L; Burn J; Falabella R; Gatto EM; Ishii N
    Am J Hum Genet; 1995 Jan; 56(1):58-66. PubMed ID: 7529964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.
    Kawagishi J; Kumabe T; Yoshimoto T; Yamamoto T
    Genomics; 1995 Nov; 30(2):224-32. PubMed ID: 8586421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human piebaldism: six novel mutations of the proto-oncogene KIT.
    Syrris P; Heathcote K; Carrozzo R; Devriendt K; Elçioglu N; Garrett C; McEntagart M; Carter ND
    Hum Mutat; 2002 Sep; 20(3):234. PubMed ID: 12204004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
    Giebel LB; Spritz RA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8696-9. PubMed ID: 1717985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.